Name of opportunity: 👀
Pfizer Inc
Is it undervalued?: 📈
Pfizer is currently priced 5.93% cheaper than it was a month ago, and analysts are saying that it might be ‘undervalued’. At its highest price in the last 5 years, it was worth $59.48 during Covid due to the success of its vaccine - but now, the price is nearly half that, at $27.48.
How hot is this investment opportunity? 🔥🔥🔥
Check out Pfizer’s page in our investing app Nemo Money. Analysts predict the price of Pfizer Inc. might increase from $27.47 to $31.49 in the next 12 months. If you invested $1000, you might profit $147.02.
One reason why analysts think that Pfizer might increase in value is because of a new drug the company is developing. Danuglipron will be Pfizer’s contribution to the increasingly busy weight loss drug market - the difference is that it will be a daily pill rather than an injection like Novo Nordisk’s Wegovy or Eli Lilly’s Zepbound.
Analysts also consider Pfizer’s dividend yield to be ‘Above Average’. The yield of 5.59% offers a solid return for income investors. If you invested $1000 you would be paid $55.90 a year in dividends (based on the last 12 months).
Drug developer: 💊
Pfizer Inc. is a research-based biopharmaceutical company. The company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. This American multinational company is headquartered in New York, US.
Which neme?: 🔍
7 Stocks With Dual Potential’, ‘Pharma’, and ‘Dividend Deadlines’
Download Nemo Money to check out Pfizer - if you’re a new user, you can access our registration bonus. We’ll give you 50% of the first $50 you top up with (or 50% of any amount up to that).
